We are live on ! Find out more
FCM

Fairholme Capital Management Portfolio holdings

AUM $1.49B
1-Year Est. Return 28.35%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+28.35%
3 Year Est. Return
+36.16%
5 Year Est. Return
+56.7%
10 Year Est. Return
+189.85%
AUM
$1.49B
AUM Growth
-$24.3M
Cap. Flow
-$28.6M
Cap. Flow %
-1.92%
Top 10 Hldgs %
99.76%
Holding
13
New
3
Increased
4
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$18M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$6.49M
3
PFE icon
Pfizer
PFE
+$6.04M
4
UPS icon
United Parcel Service
UPS
+$2.47M
5
CPB icon
Campbell Soup
CPB
+$2.46M

Top Sells

Rank Stock Value
1
JOE icon
St. Joe Company
JOE
+$67.4M

Sector Composition

Rank Sector Weight
1 Real Estate 76.43%
2 Energy 13.46%
3 Financials 9.02%
4 Consumer Staples 0.49%
5 Healthcare 0.37%

No holdings matched the selected filter criteria.

Similar funds

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return

Fairholme Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Fairholme Capital Management held 13 positions worth $1.49B, down 1.6% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Fairholme Capital Management's Q2 2026 filing shows 3 new, 4 increased and 1 reduced positions. Its largest new stake was Pfizer: 231,000 shares worth $5.56M. The largest sale was St. Joe Company, an estimated $67.4M.

By sector, the portfolio is most concentrated in Real Estate at 76% of assets, down from 80% a quarter earlier, followed by Energy and Financials.

  • Fairholme Capital Management's largest Q2 2026 buy was Pfizer: 231,000 shares worth $5.56M.
  • Fairholme Capital Management added most to Berkshire Hathaway Class B in Q2 2026, an estimated $18M increase.
  • Fairholme Capital Management's biggest Q2 2026 reduction was St. Joe Company, cutting an estimated $67.4M.
  • Fairholme Capital Management's ten largest holdings make up 100% of its $1.49B portfolio in Q2 2026.
  • Fairholme Capital Management opened 3 new positions and closed 0 in Q2 2026.
  • Fairholme Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.49B.

Based on Fairholme Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.